A more responsible approach to longevity therapy.
Start with your health, goals, and baseline markers—then consider targeted therapies with a clear discussion of evidence, uncertainty, safety, and alternatives.
- Slower recovery
- Loss of strength or lean mass
- Low energy
- Changing body composition
- Sleep or resilience concerns
- Healthy-aging goals
Symptoms can have many causes. Your evaluation helps determine the right next step.
Licensed provider-led care
Comprehensive lab review
100% virtual appointments
Clear cash-pay pricing
The goal is not more treatments. It is better-selected care.
Longevity care should begin with sleep, metabolic health, hormones, nutrition, movement, and established risk factors—not a catalog of injections.
When a peptide, compounded therapy, or other longevity option is considered, your provider reviews the quality of evidence, limitations, potential risks, monitoring needs, and whether it meaningfully fits your goals.
Start with foundations
Identify the health factors most likely to affect energy, recovery, body composition, and long-term risk before adding therapy.
Select with purpose
Consider options such as sermorelin or other clinician-guided therapies only when the rationale and expected role are clear.
Be honest about evidence
Separate established uses from experimental options and discuss uncertainty rather than presenting every therapy as proven.
Baseline information makes treatment more intentional.
Monitoring varies by the therapy being considered and may include metabolic, hormone, blood-count, liver, kidney, and other safety markers.
Testing is individualized. Your provider will recommend only the labs appropriate for your history, symptoms, and goals.
Care that moves from questions to a clear plan.
Define the real goal
Clarify whether the priority is recovery, body composition, energy, sleep, healthy aging, or another measurable concern.
Review health and evidence
Evaluate baseline health, contraindications, current medications, and what is—and is not—known about the options.
Choose conservatively
Proceed only when a therapy is clinically appropriate and you understand expected benefits, uncertainty, alternatives, and cost.
Monitor and reconsider
Track response and safety, and discontinue or change course when the treatment is not providing meaningful value.
Understand the therapy before you commit.
Longevity and compounded-therapy costs vary. You receive the exact treatment and medication price before deciding whether to proceed.
Treatment pricing depends on the therapy selected after clinical evaluation.
- Individual medical evaluation
- Evidence and risk discussion
- Personalized treatment selection
- Monitoring plan when treatment proceeds
Designed for: adults seeking a clinician-guided discussion of recovery, body composition, healthy aging, or peptide options—not a predetermined prescription.
No therapy is guaranteed or prescribed without an individual evaluation.
Before you begin.
No. Some compounded peptide options are not FDA-approved and may have limited human safety and effectiveness data. Your provider will explain the regulatory status, evidence limitations, known risks, and alternatives for the specific therapy being discussed.
Availability depends on current law, pharmacy standards, and clinical appropriateness. These substances are not FDA-approved, and FDA has identified limited safety information and potential compounding risks. They are never presented as proven treatments.
No. Symptoms, health history, contraindications, baseline evaluation, goals, and monitoring needs must be reviewed before any growth-hormone–related therapy is considered.
Not automatically. Adding more therapies can increase cost, uncertainty, side effects, and interaction risk. Your provider prioritizes the smallest reasonable plan for the clinical goal.